Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy

被引：24

作者：

Kang, Bo-Sung ^{[1
]}

Bang, Moon Suk ^{[1
]}

Jung, Se Hee ^{[1
]}

机构：

[1] Seoul Natl Univ, Coll Med, Dept Rehabil Med, Seoul 110744, South Korea

来源：

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION | 2007年 / 86卷 / 11期

关键词：

cerebral palsy; spasticity; botulinum toxin; electrical stimulation;

D O I：

10.1097/PHM.0b013e3181520449

中图分类号：

R49 [康复医学];

学科分类号：

100215 ;

摘要：

Objective: To assess the additive effect of adjuvant electrical stimulation on botulinum toxin A injection in children with spastic diplegic cerebral palsy. Design: Eighteen children with dynamic foot equinus deformity were treated with botulinum toxin A injection into the calf muscles. Seven children were assigned to a treatment group who received botullnum toxin A and adjuvant electrical stimulation, and 11 children were assigned to a control group with botulinum toxin injection only. Before botulinum injection, and at 2 wks and 3 mos after injection, the Physician Rating Scale, passive ranges of ankle and knee motion, and the modified Ashworth scale were measured. Results: A significant increase In passive range of ankle motion was observed at 2 wks after injection in the treatment group and at 3 mos after injection in both groups. Both groups showed significant improvements by the modified Ashworth scale at 2 wks after injection. Subscales of the Physician Rating Scale (equinus foot, crouched gait) and total Physician Rating Scale scores were significantly improved in the treatment group at 3 mos after injection, but this was not observed in the control group. Conclusions: Adjuvant electrical stimulation for a short period after botulinum toxin A injection was found to benefit early improvement of range of motion and maintenance of gait improvement in children with spastic diplegia cerebral palsy showing dynamic equinus.

引用

页码：901 / 906

页数：6

共 30 条

[11]

COSGROVE AP, 1994, DEV MED CHILD NEUROL, V36, P386

[12] The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans [J].

Eleopra, R ;

Tugnoli, V ;

DeGrandis, D .

MOVEMENT DISORDERS, 1997, 12 (01) :89-94

[13]

Gage JR., 1991, Gait Analysis in Cerebral Palsy

[14] Recommendations for the use of botulinum toxin type A in the management of cerebral palsy [J].

Graham, HK ;

Aoki, KR ;

Autti-Rämö, I ;

Boyd, RN ;

Delgado, MR ;

Gaebler-Spira, DJ ;

Gormley, ME ;

Guyer, BM ;

Heinen, F ;

Holton, AF ;

Matthews, D ;

Molenaers, G ;

Motta, F ;

Ruiz, PJG ;

Wissel, J .

GAIT & POSTURE, 2000, 11 (01) :67-79

[15] DEVELOPMENT OF RESISTANCE TO BOTULINUM TOXIN TYPE-A IN PATIENTS WITH TORTICOLLIS [J].

GREENE, P ;

FAHN, S ;

DIAMOND, B .

MOVEMENT DISORDERS, 1994, 9 (02) :213-217

[16] An assessment of gait analysis in the rehabilitation of children with walking difficulties [J].

Hailey, D ;

Tomie, JA .

DISABILITY AND REHABILITATION, 2000, 22 (06) :275-280

[17] Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients [J].

Hesse, S ;

Jahnke, MT ;

Luecke, D ;

Mauritz, KH .

NEUROSCIENCE LETTERS, 1995, 201 (01) :37-40

[18] NERVE GROWTH IN BOTULINUM TOXIN POISONED MUSCLES [J].

HOLLAND, RL ;

BROWN, MC .

NEUROSCIENCE, 1981, 6 (06) :1167-1179

[19] INFLUENCE OF NERVE-ENDING ACTIVITY AND OF DRUGS ON RATE OF PARALYSIS OF RAT DIAPHRAGM PREPARATIONS BY CL BOTULINUM TYPE A TOXIN [J].

HUGHES, R ;

WHALER, BC .

JOURNAL OF PHYSIOLOGY-LONDON, 1962, 160 (02) :221-&

[20] RESPONSE AND IMMUNORESISTANCE TO BOTULINUM TOXIN INJECTIONS [J].

JANKOVIC, J ;

SCHWARTZ, K .

NEUROLOGY, 1995, 45 (09) :1743-1746

← 1 2 3 →